GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Array Biopharma Inc. (ARRY) [hlAlert]

Rating:
Outperform
ARRY
up 54.90 %

Array Biopharma Inc. (ARRY) rated Outperform by Wells Fargo

Posted on: Thursday,  Dec 20, 2012  8:25 AM ET by Wells Fargo

Wells Fargo rated Outperform Array Biopharma Inc. (NASDAQ: ARRY) on 12/20/2012, when the stock price was $3.77. Since
then, Array Biopharma Inc. has gained 54.91% as of 01/15/2016's recent price of $5.84.
If you would have followed this Wells Fargo's recommendation on ARRY, you would have gained 54.9% of your investment in 1121 days.

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases. The company's proprietary drug development pipeline is focused on the treatment of cancer and inflammatory disease and includes clinical candidates that are designed to regulate therapeutically important targets. In addition, leading pharmaceutical and biotechnology companies collaborate with Array to discover and develop drug candidates across a broad range of therapeutic areas.

The investment research content is provided by Wells Capital Management, a registered investment adviser and wholly owned subsidiary of Wells Fargo Bank, N.A. Our economists’ expertise on domestic markets, and national and global trends, is an important resource to the firm. Wells Capital Management economists are known for their thoughts on investment strategy, macro-economic forecasts and other top-down analysis, and share their views on bonds, midcaps and liquidity management in their publications.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/20/2012 8:25 AM Buy
None
3.77
as of 12/31/2012
1 Week up  3.33 %
1 Month down  -1.32 %
3 Months   
1 YTD down  -1.32 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy